Sajal Kumar Halder

Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: an in silico molecular modeling approach in battling the COVID-19 outbreak

Mohammad Mahfuz Ali Khan Shawan, Sajal Kumar Halder, Md. Ashraful Hasan · Bulletin of the National Research Centre/Bulletin of the National Research Center · 2021 · 86 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Using Chitosan or Chitosan Derivatives in Cancer Therapy

Md Salman Shakil, Kazi Mustafa Mahmud, Mohammad Sayem et al. · Polysaccharides · 2021 · 78 citations · Full text

Pharmacy, Oncology, Pharmacology +17

In Silico Identification and Analysis of Potentially Bioactive Antiviral Phytochemicals against SARS‐CoV‐2: A Molecular Docking and Dynamics Simulation Approach

Sajal Kumar Halder, Ive Sultana, Md Istiaq Mohhamad Shuvo et al. · BioMed Research International · 2023 · 45 citations · Full text

Pharmacy, Infectious Diseases, Medicinal Chemistry +17

A Comprehensive Study to Unleash the Putative Inhibitors of Serotype2 of Dengue Virus: Insights from an In Silico Structure-Based Drug Discovery

Sajal Kumar Halder, Iqrar Ahmad, Jannatul Fardous Shathi et al. · Molecular Biotechnology · 2022 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +15

Identification of the most damaging nsSNPs in the human CFL1 gene and their functional and structural impacts on cofilin-1 protein

Sajal Kumar Halder, Md. Oliullah Rafi, Esha Binte Shahriar et al. · Gene · 2022 · 29 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17